title: Experience with prostate-specific antigen in prostatic carcinoma.
abstract: A total of 71 prostatic tumour patients and 45 prostatic adenoma patients were tested for prostate-specific antigen (PSA), immunological prostatic acid phosphatase (PAP) concentration as well as serum prostatic phosphatase (SPP) and enzymic serum phosphatase. It was found among untreated patients that PSA showed the highest percentage of pathologic affection in each stage. PSA, on the evidence of clearance test in the initial days of therapy and after a follow-up period of several months, gave a good picture of the course that the disease had taken.
authors.affiliation: Department of Urology, St. Agnes Hospital, Bocholt, FRG.
authors.forename: I
authors.initials: I
authors.lastname: Romics
authors.forename: D
authors.initials: D
authors.lastname: Bach
mesh_terms: D000135:Acid Phosphatase / Q000032:analysis; D000368:Aged; D000369:Aged, 80 and over; D000951:Antigens, Neoplasm / Q000032:analysis*; D014408:Biomarkers, Tumor / Q000032:analysis*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010744:Phosphoric Monoester Hydrolases / Q000032:analysis; D011467:Prostate / Q000201:enzymology; D017430:Prostate-Specific Antigen; D011471:Prostatic Neoplasms / Q000175:diagnosis*
chemical_list: D000951:Antigens, Neoplasm; D014408:Biomarkers, Tumor; D000135:Acid Phosphatase; D010744:Phosphoric Monoester Hydrolases; D017430:Prostate-Specific Antigen